Mukhammadali Jumayev

4 та иш

5th-year student, General Medicine Bukhara University of Innovative Education and Medicine

1. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   МақолаDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.005208

2. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   МақолаDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.005264

3. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   МақолаDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.005352

4. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   МақолаDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.005357